Join
Live feed
·
PRReleasevia Quantisnow
Abeona Therapeutics Inc. logo
Bio-Techne Corp logo

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABEO (Abeona Therapeutics Inc.), TECH (Bio-Techne Corp) and more on Quantisnow.